Benjamin R. tenOever
- PROFESSOR Microbiology
- Cellular Immunity
- Infectious Disease
- Influenza Virus
- Interferon Antagonists
- Mass Spectrometry
- Molecular Biology
- RNA Splicing & Processing
- Respiratory Tract
- Signal Transduction
- Transcription Factors
- Transgenic Mice
- Vaccine Development
- Viruses and Virology
Ph.D., McGill University
Watch a video featuring the Microbiology and Virology PhD Graduate School Program.
American Society of Virology Ann Palmenberg Award
American Society of Virology (ASV)
Investigator in the Pathogenesis of Infectious Diseases
Burroughs Wellcome Fund
Cozzarelli Prize Recipient in Biomedical Sciences
National Academy of Science
Young Investigator Award
American Society for Microbiology
Milstein Young Investigator Award
International Society of Interferon and Cytokine Research
Pew Charitable Trust in Biomedical Sciences
Presidential Early Career Award for Scientists and Engineers (PECASE)
National Science and Technology Council
Specific Clinical/Research Interests: Host-Pathogen Interactions
Current Students: Andrew Varble, Mark Chua, Jillian Shapiro, Asiel Benitez
Postdoctoral Fellows: Sonja Schmid, Ryan Langlois, Simone Backes
Research Personnel: Maryline Panis, Ismarc Ryes
The tenOever lab broadly focuses on the molecular interactions between viruses and their host. More specifically, the lab studies the host transcriptional response to infection and the means by which the virus circumvents these activities to propagate the infection. This research encompasses the study of cellular antiviral proteins and small RNAs, of both cellular and virus origin, which contribute to the outcome of infection. The overall objective of this lab is to gain a thorough understanding of the molecular basis of virus pathogenicity in an effort to generate improved vaccines and therapeutics.
Summary of Research Studies:
We focus on the interplay between RNA viruses and small RNAs. This research includes the study of miRNAs and Y-RNAs and their role, if any, in the cellular response to virus infection, the exploitation of miRNAs to control virus tropism, virus synthesis of miRNAs, and the biology of virus-derived small RNAs. Our laboratory uses several techniques to study these RNA-based host-virus interactions including genetic manipulation of both host and pathogen. We are presently working in the following areas.
Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, tenOever BR. MicroRNA-Mediated Species-Specific Attenuation of Influenza A Virus. Nat Biotechnol 2009 Jun; 27(6): 572-576.
Perez JT, Varble A, Sachidanandam R, Zlatev I, Manoharan M, García-Sastre A, tenOever BR. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proceedings of the National Academy of Sciences of the United States of America 2010 Jun; 107(25).
Shapiro JS, Varble A, tenOever BR. Non-Canonical Cytoplasmic Processing of Viral microRNAs. RNA 2010; 16: 2068-74.
Varble A, Chua MA, Perez JT, Manicassamy B, Garcia-Sastre A, tenOever BR. Engineered RNA Viral Synthesis of microRNAs. PNAS 2010; 107(25): 11519-24.
Schmid S, Mordstein M, Kochs G, Garcia-Sastre A, tenOever BR. Transcription Factor Redundancy Ensures Induction of the Antiviral State. JBC 2010; 285(53): 42013-22.
Langlois RA, Shapiro JS, Pham AM, tenOever BR. In vivo delivery of cytoplasmic RNA virus-derived miRNAs. Molecular therapy : the journal of the American Society of Gene Therapy 2012 Feb; 20(2).
Pham AM, Langlois RA, TenOever BR. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS pathogens 2012 Jan; 8(1).
Shapiro JS, Langlois RA, Pham AM, Tenoever BR. Evidence for a cytoplasmic microprocessor of pri-miRNAs. RNA (New York, N.Y.) 2012 Jul; 18(7).
Langlois RA, Varble A, Chua MA, García-Sastre A, tenOever BR. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proceedings of the National Academy of Sciences of the United States of America 2012 Jul; 109(30).
Backes S, Shapiro JS, Sabin LR, Pham AM, Reyes I, Moss B, Cherry S, tenOever BR. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell host & microbe 2012 Aug; 12(2).
Perez JT, Zlatev I, Aggarwal S, Subramanian S, Sachidanandam R, Kim B, Manoharan M, tenOever BR. A small-RNA enhancer of viral polymerase activity. Journal of virology 2012 Dec; 86(24).
Chua MA, Schmid S, Perez JT, Langlois RA, Tenoever BR. Influenza A Virus Utilizes Suboptimal Splicing to Coordinate the Timing of Infection. Cell reports 2013 Jan;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. tenOever did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 16 Room 16-60 (Lab)
1468 Madison Avenue
New York, NY 10029
Annenberg Building Floor 16 Room 16-60C
1468 Madison Avenue
New York, NY 10029